Association of Charlson–Deyo Comorbidity Index With Survival Following Upfront Laryngectomy for Laryngeal Squamous Cell Carcinoma
Open Access
- 14 June 2026
- journal article
- research article
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 11 (3) , e70469
Abstract
Objective: Charlson–Deyo Comorbidity Index (CCI) predicts 10‐year mortality for a patient based on a range of comorbid conditions. Objective preoperative risk assessment tools inform physician decision making. Our study examines the relationship between CCI and overall survival (OS) following upfront laryngectomy for laryngeal squamous cell carcinoma (LSCC). Methods: A retrospective analysis of the 2004–2016 National Cancer Database (NCDB) was conducted to identify adult patients with pT1‐4 N0‐3 M0 LSCC undergoing upfront laryngectomy. Kaplan–Meier survival analysis and Cox proportional hazards modeling were performed to evaluate the association between CCI and OS. Results: Of the 25,720 patients satisfying inclusion criteria, 16,204 (63.0%) were CCI = 0, 6812 (26.5%) were CCI = 1, 1948 (7.6%) were CCI = 2, and 756 (2.9%) were CCI ≥ 3. On univariate analysis, CCI groups differed by age (65.1% were < 65 years old in CCI = 0 vs. 57.3%, 49.6%, and 48.9% in CCI = 1, 2, and ≥ 3; p < 0.001), sex ( p < 0.001), and race ( p < 0.001). Differences also existed across CCI groups in primary site, T‐stage, N‐stage, systemic therapy, and radiotherapy ( p < 0.001). On Kaplan–Meier analysis, 5‐year OS for CCI = 0, 1, 2, and ≥ 3 was 55.3%, 47.8%, 39.5%, and 34.0%, respectively ( p < 0.001). CCI = 1 (aHR 1.20, 95% CI 1.14–1.26, p < 0.001), CCI = 2 (aHR 1.57, 95% CI 1.45–1.71, p < 0.001), and CCI ≥ 3 (aHR 1.77, 95% CI 1.56–2.01, p < 0.001) were associated with worse OS than CCI = 0. Conclusion: In an adult cohort with pT1‐4 N0‐3 M0 LSCC undergoing upfront laryngectomy, increasing CCI was associated with worse OS. During perioperative counseling, CCI should be optimized and considered as a factor influencing survival outcomes. Level of Evidence: 4.Keywords
This publication has 42 references indexed in Scilit:
- Oncologic and Functional Outcomes of Surgical and Nonsurgical Treatment of Advanced Squamous Cell Carcinoma of the Supraglottic LarynxJAMA Otolaryngology–Head & Neck Surgery, 2015
- Organ Preservation for Advanced Larynx Cancer: Issues and OutcomesJournal of Clinical Oncology, 2015
- Survival Outcomes in Advanced Laryngeal CancerJAMA Otolaryngology–Head & Neck Surgery, 2014
- The impact of comorbidity on cancer survival: a reviewClinical Epidemiology, 2013
- Retrospective Analysis of Prognostic Factors in 205 Patients with Laryngeal Squamous Cell Carcinoma Who Underwent Surgical TreatmentPLOS ONE, 2013
- The Impact of Comorbidity on Treatment (Chemoradiation and Laryngectomy) of Advanced, Nondistant Metastatic Laryngeal CancerJAMA Otolaryngology–Head & Neck Surgery, 2012
- Comparison of the Adult Comorbidity Evaluation 27 and the Charlson Comorbidity indices in patients with laryngeal squamous cell carcinomaThe Journal of Laryngology & Otology, 2012
- The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United StatesAnnals of Surgical Oncology, 2008
- Comorbidity Measurement in Patients with Laryngeal Squamous Cell CarcinomaORL, 2007
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992